Erin Macrae R MD

Erin Macrae R MD
Asst ProfessorCollege of
Starling Loving Hall 320 W 10th Avenue Columbus Ohio 43210
Phone:614-366-8541Fax: (614) 293-7264
  • Translational Therapeutics

General Research Interest

Novel therapeutics in breast cancer; HER2 positive breast cancer.

Research Description

Dr. Macrae's research is focused on clinical and translational investigation, discovering mechanisms of sensitivity and resistance to trastuzumab through the utilization of biomarkers and the identification of novel therapeutic approaches.

Current Publications

  • Oostra DR, Macrae ERRole of trastuzumab emtansine in the treatment of HER2-positive breast cancer.Breast Cancer (Dove Med Press) 6 103-13 1/1/2014
  • Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, Mrozek E, Olson E, Wesolowski RDocetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.Support Care Cancer 21 2679-86 10/1/2013
  • Olson EM, Abdel-Rasoul M, Maly J, Wu CS, Lin NU, Shapiro CLIncidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.Ann Oncol 24 1526-33 6/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: